Evidence map›Paper›PMID 36627585›Full record

ArticleBMC ophthalmology2023

Independent-effect comparison of five crosslinking procedures for Progressive Keratoconus based on Keratometry and the ABCD Grading System using Generalized Estimating Equations (GEE).

Yu Liu, Dan Shen, Hao-Yu Wang, Deng-Feng Liang, Qing-Yan Zeng

Abstract read
In one paragraph

Article in BMC ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu LiuAier School of Ophthalmology, Central South University, Changsha, China.
Dan ShenHankou Aier Eye Hospital, Wuhan, China.
Hao-Yu WangHankou Aier Eye Hospital, Wuhan, China.
Deng-Feng LiangHankou Aier Eye Hospital, Wuhan, China.
Qing-Yan ZengAier School of Ophthalmology, Central South University, Changsha, China. zengqingyan1972@163.com.

Funding

the Research Fund of the Clinical Research Institute of Aier Eye Hospital Group AR2110D22the scientific research project of the Health Commission of Hubei Province WJ2021M034the scientific research project of the Health Commission of Wuhan WX20Q19
6 · The paper itself

Abstract

purposeCorneal collagen crosslinking (CXL) is an effective treatment for progressive keratoconus. Multiple CXL modalities are clinically available. The present study compared the 1 year outcomes of five types of CXL procedures for progressive keratoconus in a Chinese population using generalized estimating equations (GEE).

methodsThis retrospective study included 239 eyes in 171 patients with keratoconus who underwent CXL and were followed up for 1 year. Five CXL procedures were assessed, including Accelerated Transepithelial CXL, Iontophoresis CXL for 10 min, CXL plus phototherapeutic keratectomy (CXL-plus-PTK), High-Fluence Accelerated CXL, and Accelerated CXL. Patients treated with the Accelerated CXL procedure represented the reference group. Primary outcomes were visual acuity change, spherical equivalence, endothelial cell density, mean keratometry (K

resultsThe Accelerated Transepithelial CXL group had lower performance than the Accelerated CXL group according to K

conclusionsThe CXL-plus-PTK procedure was more effective than the Accelerated CXL procedure based on K

Indexed as

KeratoconusPhotochemotherapyCollagenCorneal TopographyCross-Linking ReagentsFollow-Up StudiesHumansPhotosensitizing AgentsRetrospective StudiesRiboflavinUltraviolet RaysCollagenCross-Linking ReagentsPhotosensitizing AgentsRiboflavinABCD Grading SystemCrosslinkingGEEKeratoconusPTK

Identifiers

PMID36627585
PMCPMC9830808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.